Drawing for OCULAR THERAPEUTIX

USPTO serial 97401659

OCULAR THERAPEUTIX

Reviewed by CopyMark Law Group

Reg. 7393527Status 700Registered
Filing date
Status date
Registration date
May 21, 2024
Examiner
DOMBROW, COLLEEN M
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with OCULAR THERAPEUTIX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Matthew P. Hintz, Esq.

Matthew P. Hintz, Esq. Lowenstein Sandler, LLPOne Lowenstein DriveRoseland, NJ 07068United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceuticals for treatment of ophthalmic diseases and conditions; Ophthalmic preparations; Pharmaceutical preparations for the treatment of eye diseases and conditions; Medical inserts namely, implantable intravitreal drug delivery devices sold filled with ophthalmic pharmaceutical preparations for treating glaucoma, dry eye disease, macular degeneration, and lowering intraocular pressure; Pharmaceutical preparations for the treatment of glaucoma, dry eye disease, and macular degeneration; Pharmaceutical preparations for the treatment of lowering intraocular pressure; Medical insert, namely, implantable intravitreal drug delivery devices sold filled with pharmaceutical preparations in the nature of dexamethasone for the treatment of eye diseases and conditions; Medical insert, namely, implantable intravitreal drug delivery devices sold filled with pharmaceutical preparations in the nature of dexamethasone for post-op pain and inflammation of the eye, and itching associated with allergic conjunctivitisACTIVE—
042Research and development in the pharmaceutical and biopharmaceutical fields; Development of pharmaceutical and biopharmaceutical preparations, inserts, implants, and medicines; Pharmaceutical and biopharmaceutical products developmentACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 24, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 24, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 24, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 24, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 24, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 21, 2024NRCSNOTICE OF REGISTRATION CONFIRMATION EMAILED—
May 21, 2024R.SRREGISTERED-SUPPLEMENTAL REGISTERYour mark is registered on the Supplemental Register, which is available for marks that are not yet distinctive enough for the Principal Register but can still identify a source. Protection is more limited than Principal Register registration but can later support a Principal Register application.
Apr 15, 2024CNTAAPPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER—
Apr 12, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 12, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 12, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 3, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 3, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 3, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 6, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 6, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 4, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 6, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 6, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 6, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 5, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 5, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 5, 2023ALIEASSIGNED TO LIE—
Jun 2, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 2, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 2, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 2, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 30, 2022DOCKASSIGNED TO EXAMINER—
Oct 10, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Oct 10, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 10, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 17, 2022MDSMNOTICE OF DESIGN SEARCH CODE E-MAILED—
May 16, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 12, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance